PFE vs SNY: stock comparison and AI forecast
Pfizer Inc (PFE) and Sanofi (SNY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
PFE Pfizer Inc
- Price
- $29.39 +11.0% · 6M
- Market Cap
- $167.51B
- P/E Ratio
- 37.2x
- Size
- large-cap
- AI Forecast
SNY Sanofi
- Market Cap
- $115.97B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- PFE is 1.4 times larger than SNY by market capitalization ($167.51B against $115.97B).
- PFE yields 5.85% in dividends; SNY pays none.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | PFE | SNY |
|---|---|---|
| Market Cap | $167.51B | $115.97B |
| P/E Ratio | 37.20x | – |
| P/B Ratio | 1.88x | – |
| Dividend Yield | 5.85% | – |
| EPS | $0.79 | – |
| Book Value/Share | $15.62 | – |
| Revenue/Share | $11.16 | – |
| FCF/Share | $2.07 | – |
Profitability & Margins
| Metric | PFE | SNY |
|---|---|---|
| ROE | 4.5% | 30.0% |
| ROA | 2.0% | 16.9% |
| ROIC | – | 20.7% |
| Gross Margin | 73.4% | – |
| Net Margin | 6.3% | – |
| EBT Margin | 6.7% | – |
| Tax Rate | 4.4% | – |
Financial Health
| Metric | PFE | SNY |
|---|---|---|
| Current Ratio | 1.42x | 1.09x |
| Quick Ratio | 1.10x | 0.73x |
| D/E Ratio | 1.29x | – |
| Financial Leverage | 2.30x | 1.78x |
| Working Capital | $13.28B | $3.06B |
Cash Flow
| Metric | PFE | SNY |
|---|---|---|
| Operating Cash Flow | $14.17B | $28.11B |
| Free Cash Flow | $11.79B | – |
| Capital Spending | -$2.39B | – |
| OCF Growth YoY | 8.4% | -11.9% |
| FCF Growth YoY | 13.6% | – |
| FCF/Sales | 18.5% | – |
| CapEx/Sales | 3.8% | – |
Operational Efficiency
| Metric | PFE | SNY |
|---|---|---|
| Asset Turnover | 0.31x | – |
| Receivables Turnover | 4.5x | – |
| Inventory Turnover | 1.7x | 3.8x |
| Fixed Assets Turnover | 3.3x | – |
| Days Sales Outstanding | 81 days | – |
| Days Inventory | 216 days | 96 days |
| Payables Period | 88 days | – |
| Cash Conversion Cycle | 210 days | – |
Income Statement
| Metric | PFE | SNY |
|---|---|---|
| Total Revenue | $63.62B | – |
| Operating Income | – | $23.11B |
| Net Income | $4.03B | $24.28B |
| R&D Expense | $11.52B | $25.35B |
| SG&A Expense | $13.81B | $32.28B |
| Cost of Goods Sold | $16.94B | $44.17B |
Dividend & Shareholder Information
| Metric | PFE | SNY |
|---|---|---|
| Dividends Per Share | $1.72 | – |
| Payout Ratio | 217.7% | – |
| Shares Outstanding | 5700M | 2465M |
| Net Income Growth | -59.0% | 5.1% |
| EPS Growth | -55.1% | – |
PFE vs SNY: stock comparison and AI forecast
Which is bigger, PFE or SNY?
PFE is 1.4 times larger than SNY by market capitalization ($167.51B against $115.97B).
Which one does Intratio's AI model rank higher, PFE or SNY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.